US2017028129A1PendingUtilityA1

Blood glucose reduction

Assignee: RAINBOW MEDICAL LTDPriority: Mar 5, 2014Filed: Oct 11, 2016Published: Feb 2, 2017
Est. expiryMar 5, 2034(~7.6 yrs left)· nominal 20-yr term from priority
Inventors:Yossi Gross
A61N 1/056A61M 2230/42A61N 1/05A61M 2230/62A61M 2230/06A61N 1/36007A61M 2230/63A61M 5/1723
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for use with a blood-glucose-reduction device is provided. The method includes using a sensor, sensing a parameter indicative of a level of skeletomotor activity of a subject, and generating a signal in response thereto. In response to the signal from the sensor indicating that the level of skeletomotor activity exceeds a skeletomotor-activity threshold, reduction of blood glucose of the subject is reduced by the blood-glucose-reduction device.

Claims

exact text as granted — not AI-modified
1 - 69 . (canceled) 
     
     
         70 . A method for use with a blood-glucose-reduction device, the method comprising:
 using a sensor, sensing a parameter indicative of a level of skeletomotor activity of a subject, and generating a signal in response thereto; and   in response to the signal from the sensor indicating that the level of skeletomotor activity exceeds a skeletomotor-activity threshold, reducing reduction of blood glucose of the subject by the blood-glucose-reduction device.   
     
     
         71 . The method according to  claim 70 , wherein the sensor comprises an accelerometer coupled to the subject, the method comprising reducing reduction of blood glucose of the subject by the blood-glucose-reduction device in response to a signal from the accelerometer indicating that the level of skeletomotor activity exceeds the skeletomotor-activity threshold. 
     
     
         72 . The method according to  claim 71 , wherein the accelerometer is implanted in the subject, the method comprising reducing reduction of blood glucose of the subject by the blood-glucose-reduction device in response to the signal from the accelerometer indicating that the level of skeletomotor activity exceeds the skeletomotor-activity threshold. 
     
     
         73 . The method according to  claim 70 , wherein reducing reduction of blood glucose of the subject by the blood-glucose-reduction device comprises reducing reduction of blood glucose of the subject by the blood-glucose-reduction device in response to the signal from the sensor indicating that the subject is running. 
     
     
         74 . The method according to  claim 70 , wherein the sensor comprises a heart-rate sensor, the method comprising reducing reduction of blood glucose of the subject by the blood-glucose-reduction device in response to a signal from the heart-rate sensor indicating that a heart rate of the subject exceeds a heart-rate threshold. 
     
     
         75 . The method according to  claim 70 , wherein the sensor comprises a breathing-rate sensor, the method comprising reducing reduction of blood glucose of the subject by the blood-glucose-reduction device in response to a signal from the breathing-rate sensor indicating that a breathing rate of the subject exceeds a breathing-rate threshold. 
     
     
         76 . The method according to  claim 70 , wherein the blood-glucose-reduction device is a pancreatic stimulator, the method being for use with the pancreatic stimulator. 
     
     
         77 . The method according to  claim 70 , wherein the blood-glucose-reduction device is an insulin pump, the method being for use with the insulin pump. 
     
     
         78 . A method for use with a blood-glucose-reduction device, the method comprising:
 using a sensor, sensing a parameter indicative of a level of skeletomotor activity of a subject, and generating a signal in response thereto; and   in response to the signal from the sensor indicating that the subject is likely to be sleeping, reducing reduction of blood glucose of the subject by the blood-glucose-reduction device.   
     
     
         79 . The method according to  claim 78 , wherein the sensor comprises an accelerometer coupled to the subject, the method comprising reducing reduction of blood glucose of the subject by the blood-glucose-reduction device in response to a signal from the accelerometer indicating that the subject is lying down. 
     
     
         80 . The method according to  claim 78 , wherein the sensor comprises a heart-rate sensor, the method comprising reducing reduction of blood glucose of the subject by the blood-glucose-reduction device in response to a signal from the heart-rate sensor indicating that a heart rate of the subject is less than a heart-rate threshold. 
     
     
         81 . The method according to  claim 78 , wherein the sensor comprises a breathing-rate sensor, the method comprising reducing reduction of blood glucose of the subject by the blood-glucose-reduction device in response to a signal from the breathing-rate sensor indicating that a breathing rate of the subject is less than a breathing-rate threshold. 
     
     
         82 . Apparatus comprising:
 a sensor, configured to sense a parameter indicative of a level of skeletomotor activity of a subject, and to generate a signal in response thereto; and   a blood-glucose-reduction device, configured to modulate a reduction of blood glucose of the subject in response to the signal from the sensor.   
     
     
         83 . The apparatus according to  claim 82 , wherein the blood-glucose-reduction device is a pancreatic stimulator. 
     
     
         84 . The apparatus according to  claim 82 , wherein the blood-glucose-reduction device is an insulin pump.

Join the waitlist — get patent alerts

Track US2017028129A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.